NCT06031675

Brief Summary

The goal of this clinicaltrial is to assess and compare isokinetic performance, surface electromyography, laboratory parameters, and cardiorespiratory function both before and after engaging in vigorous intermittent lifestyle physical activity(VILPA) within a healthy population. The main question it aims to answer is: \[1\] Does VILPA yield effective outcomes? Throughout the course of the trial, participants will engage in a simulated regimen of vigorous intermittent lifestyle physical activity for a duration of 8 weeks. The efficacy of the exercise protocol will be quantified and evaluated through the utilization of a wearable device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 12, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 31, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 11, 2023

Completed
Last Updated

September 11, 2023

Status Verified

September 1, 2023

Enrollment Period

2 months

First QC Date

August 31, 2023

Last Update Submit

September 7, 2023

Conditions

Keywords

vigorous intermittent lifestyle physical activitywearable deviceisokinetic performance

Outcome Measures

Primary Outcomes (3)

  • Isometric Strength Test

    Isokinetic muscle strength testing with the Isomed 2000

    15 minutes

  • Surface electromyography

    30 minutes

  • Exercise Flat Test

    cardiopulmonary function

    30 minutes

Secondary Outcomes (2)

  • Fasting glucose

    5 minutes

  • Blood lipid

    5 minutes

Study Arms (1)

intervention group

The intervention measures encompass the implementation of simulated vigorous intermittent lifestyle physical activity for all participants. The specific exercise regimen involves performing rope jumping activities three times a day, with each session aimed at surpassing the exercise threshold (not conducted in a continuous manner), where the heart rate should exceed 160 beats per minute. This routine will be undertaken five times a week, continuously for a span of 8 weeks.

Other: Vigorous intermittent lifestyle physical activity

Interventions

The specific exercise regimen involves performing rope jumping activities three times a day, with each session aimed at surpassing the exercise threshold (not conducted in a continuous manner), where the heart rate should exceed 160 beats per minute. This routine will be undertaken five times a week, continuously for a span of 8 weeks.

intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

University students

You may qualify if:

  • Healthy Adults
  • No exercise habits (more than 3 months)

You may not qualify if:

  • Exercising ≥ 3 times per week;
  • the presence of chronic diseases, such as hypertension, hyperglycemic states, etc;
  • have conducted an exercise program in the past three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangdong Pharmaceutical University

Guangzhou, Guangdong, 510006, China

Location

MeSH Terms

Conditions

Motor ActivityHealth Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Lizhen Liao, PhD

    Department of Health, Guangdong Pharmaceutical University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

August 31, 2023

First Posted

September 11, 2023

Study Start

May 12, 2023

Primary Completion

July 10, 2023

Study Completion

September 1, 2023

Last Updated

September 11, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations